Generation of two iPSC lines (UMi038-A & UMi039-A) from siblings bearing an Alzheimer's disease-associated variant in SORL1

Stem Cell Res. 2022 Jul:62:102823. doi: 10.1016/j.scr.2022.102823. Epub 2022 May 30.

Abstract

Alzheimer's disease (AD) is the leading cause of dementia among older adults. SORL1, a top AD risk gene, encodes an endocytic receptor involved amyloid precursor protein (APP) trafficking and processing. Rare loss-of-function SORL1 variants are a strong genetic determinant of AD, and protein-truncating mutations have been found to be causal. We derived iPSCs from two siblings affected with early-onset AD who carry a rare protein-truncating deletion in SORL1 (c.4293delC) (Kunkle et al., 2017). The iPSC lines were characterized for pluripotency, differentiation potential, and genomic stability. These lines are a valuable resource for studying pathogenic mechanisms underlying AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease* / genetics
  • Alzheimer Disease* / metabolism
  • Amyloid beta-Peptides / metabolism
  • Genetic Predisposition to Disease
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • LDL-Receptor Related Proteins / genetics
  • Membrane Transport Proteins / genetics
  • Siblings

Substances

  • Amyloid beta-Peptides
  • LDL-Receptor Related Proteins
  • Membrane Transport Proteins
  • SORL1 protein, human